A new tolypomycin-Y derivative: in vitro and in vivo antimicrobial activity.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy; D004352:Drug Resistance, Microbial; D004355:Drug Stability; D051379:Mice; D008826:Microbial Sensitivity Tests; D009281:Naphthalenes / Q000494:pharmacology / Q000627:therapeutic use; D012293:Rifampin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D009281:Naphthalenes; D012293:Rifampin